000 01240 a2200373 4500
005 20250515060921.0
264 0 _c20070404
008 200704s 0 0 eng d
022 _a0017-5749
024 7 _a10.1136/gut.2006.106021
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAssy, Nimer
245 0 0 _aWeight loss induced by orlistat reverses fatty infiltration and improves hepatic fibrosis in obese patients with non-alcoholic steatohepatitis.
_h[electronic resource]
260 _bGut
_cMar 2007
300 _a443-4 p.
_bdigital
500 _aPublication Type: Clinical Trial; Letter
650 0 4 _aAdult
650 0 4 _aAnti-Obesity Agents
_xtherapeutic use
650 0 4 _aFatty Liver
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLactones
_xtherapeutic use
650 0 4 _aLiver Cirrhosis
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aObesity
_xcomplications
650 0 4 _aOrlistat
650 0 4 _aTreatment Outcome
650 0 4 _aWeight Loss
_xdrug effects
700 1 _aHussein, Osamah
700 1 _aAbassi, Zied
773 0 _tGut
_gvol. 56
_gno. 3
_gp. 443-4
856 4 0 _uhttps://doi.org/10.1136/gut.2006.106021
_zAvailable from publisher's website
999 _c16896247
_d16896247